Cargando…
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
One of the leading causes of death worldwide, in both men and women, is cancer. Despite the significant development in therapeutic strategies, the inevitable emergence of drug resistance limits the success and impedes the curative outcome. Intrinsic and acquired resistance are common mechanisms resp...
Autores principales: | Bou Antoun, Nauf, Chioni, Athina-Myrto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418675/ https://www.ncbi.nlm.nih.gov/pubmed/37569598 http://dx.doi.org/10.3390/ijms241512222 |
Ejemplares similares
-
Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis
por: Chioni, Athina-Myrto, et al.
Publicado: (2008) -
Biological Significance and Targeting of the FGFR Axis in Cancer
por: Chioni, Athina-Myrto, et al.
Publicado: (2021) -
FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior
por: Chioni, Athina-Myrto, et al.
Publicado: (2012) -
Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3)
por: Chioni, Athina-Myrto, et al.
Publicado: (2009) -
Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis
por: Jarosz, Monika, et al.
Publicado: (2012)